BioMed Realty Trust, Inc. (BMR) Misses Q4 FFO by 1c; Guides FY13 FFO
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q4 FFO of $0.33, $0.01 worse ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
